Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Wei Jiang, Ph.D.
Guilin Medical University Affiliated Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Affiliated Hospital of Youjiang Medical University for Nationalities
Baise City, Guangxi, China
- Guigang People'S Hospital
Guigang, Guangxi, China
- Guangxi Naxishan Hospital
Guilin, Guangxi, China
- Liuzhou People'S Hospital
Liuzhou, Guangxi, China
- Nanning Monority Hospital
Nanning, Guangxi, China
- Wuzhou Red Cross Hospital
Wuzhou, Guangxi, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2015
- Primary completion
- 31 May 2021
- Completion
- 31 Dec 2021
- Last update posted
- 16 May 2018
- Registered enrollment
- 440
- Registry id
- NCT02434614
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.